[et_pb_section fb_built=”1″ _builder_version=”4.19.4″ _module_preset=”default” custom_margin=”1px||0px||false|false” custom_margin_tablet=”1px||0px||false|false” custom_margin_phone=”3px||||false|false” custom_margin_last_edited=”on|phone” custom_padding=”0px||0px||false|false” border_width_top=”0.5px” border_color_top=”#505358″ border_width_bottom=”0.5px” border_color_bottom=”#505358″ global_colors_info=”{}”][et_pb_row _builder_version=”4.19.4″ _module_preset=”default” custom_margin=”10px||10px||false|false” custom_padding=”0px||0px||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.19.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_button button_url=”@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjI1In19@” button_text=”Back to News” _builder_version=”4.19.4″ _dynamic_attributes=”button_url” _module_preset=”default” custom_button=”on” button_text_size=”12px” button_text_color=”#000000″ button_bg_color=”#FFFFFF” button_border_width=”0px” button_font=”Avant Regular||||||||” button_icon=”#||divi||400″ button_icon_color=”#89bbe5″ button_icon_placement=”left” button_on_hover=”off” custom_margin=”0px||0px||false|false” custom_padding=”0px||0px||false|false” global_colors_info=”{}” button_text_color__hover_enabled=”on|hover” button_text_color__hover=”#89bbe5″ button_bg_color__hover_enabled=”on|desktop” button_bg_color__hover=”#FFFFFF” button_bg_enable_color__hover=”on”][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ custom_padding_last_edited=”on|phone” _builder_version=”4.19.4″ _module_preset=”default” custom_padding=”80px||80px||false|false” custom_padding_tablet=”80px||80px||false|false” custom_padding_phone=”40px||80px||false|false” global_colors_info=”{}”][et_pb_row _builder_version=”4.19.4″ _module_preset=”default” custom_margin=”0px||0px||false|false” custom_padding=”0px||0px||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.19.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_post_title title=”off” author=”off” date=”off” comments=”off” featured_image=”off” module_id=”meta-new” _builder_version=”4.19.4″ _module_preset=”default” title_font=”Avant Regular||||||||” title_text_color=”#000000″ title_font_size=”64px” title_line_height=”70px” meta_font=”Calibri Regular||||||||” meta_text_color=”RGBA(255,255,255,0)” meta_font_size=”10px” meta_line_height=”16px” custom_margin=”0px||0px||false|false” custom_padding=”0px||20px||false|false” custom_css_post_meta=”text-transform: uppercase;” global_colors_info=”{}”][\/et_pb_post_title][et_pb_post_title author=”off” date_format=”j \u00b7 M \u00b7 Y” comments=”off” featured_image=”off” _builder_version=”4.21.0″ _module_preset=”default” title_font=”Avant Regular||||||||” title_text_color=”#000000″ title_font_size=”64px” title_line_height=”70px” meta_font=”Avant Regular||||||||” meta_text_color=”#000000″ meta_font_size=”14px” meta_line_height=”24px” custom_margin=”0px||0px||false|false” custom_padding=”0px||16px||false|false” title_font_size_tablet=”” title_font_size_phone=”42px” title_font_size_last_edited=”on|phone” title_line_height_tablet=”” title_line_height_phone=”48px” title_line_height_last_edited=”on|phone” custom_css_post_meta=”text-transform: uppercase;” global_colors_info=”{}”][\/et_pb_post_title][et_pb_text _builder_version=”4.27.0″ _module_preset=”default” text_font=”Avant Regular||||||||” text_text_color=”#000000″ text_font_size=”20px” text_line_height=”24px” link_text_color=”#89BBE5″ custom_margin=”0px||0px||false|false” custom_padding=”0px||0px||false|false” global_colors_info=”{}”]<\/p>\n
The DCB Innovation Challenge 2024 is entering its final round! Explore the six innovations which have been chosen to move on to the bootcamp and finale, after rigorous evaluation by our esteemed jury.<\/p>\n
[\/et_pb_text][et_pb_image src=”https:\/\/www.dcberne.com\/wp-content\/uploads\/2022\/12\/image-1.png” title_text=”Website_top6_banner1″ _builder_version=”4.27.0″ _module_preset=”default” background_image=”https:\/\/www.dcberne.com\/wp-content\/uploads\/2024\/07\/Website_top6_banner1-scaled.jpg” height=”300px” custom_margin=”64px||0px||false|false” custom_margin_tablet=”” custom_margin_phone=”48px||||false|false” custom_margin_last_edited=”on|phone” custom_padding=”0px||0px||false|false” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ custom_padding_last_edited=”on|phone” _builder_version=”4.19.4″ _module_preset=”default” custom_margin=”0px||0px||false|false” custom_padding=”0px||40px||false|false” custom_padding_tablet=”0px||40px||false|false” custom_padding_phone=”||0px||false|false” global_colors_info=”{}”][et_pb_row module_id=”post-content” _builder_version=”4.21.0″ _module_preset=”default” custom_margin=”0px||0px||false|false” custom_padding=”0px|0px|0px||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.21.0″ _module_preset=”default” custom_padding=”||0px||false|false” global_colors_info=”{}”][et_pb_testimonial portrait_url=”https:\/\/www.dcberne.com\/wp-content\/uploads\/2024\/07\/AMIC.png” quote_icon=”off” font_icon=”||divi||400″ portrait_width=”165px” portrait_height=”165px” _builder_version=”4.27.0″ _module_preset=”default” background_color=”RGBA(255,255,255,0)” width=”96.3%” custom_margin=”|151px||||” custom_padding=”|0px||||” global_colors_info=”{}”]<\/p>\n
Jorge Bondia (ES): <\/b>AMIC Health \u2013 A\u00a0digital ecosystem to educate children with type 1 diabetes through safe experimentation with gamified diabetes simulators<\/span><\/p>\n <\/i><\/p>\n \u201cAMIC Health is a digital ecosystem for the healthcare professional to educate children with type 1 diabetes through safe experimentation with gamified diabetes simulators and quantify effectiveness.\u201d<\/i><\/p>\n [\/et_pb_testimonial][et_pb_testimonial portrait_url=”https:\/\/www.dcberne.com\/wp-content\/uploads\/2024\/07\/Christine-Brannvall-CCO-scaled.jpeg” quote_icon=”off” font_icon=”||divi||400″ portrait_width=”165px” portrait_height=”165px” _builder_version=”4.27.0″ _module_preset=”default” background_color=”RGBA(255,255,255,0)” width=”96.3%” custom_margin=”|151px||||” custom_padding=”|0px||||” global_colors_info=”{}”]<\/p>\n Christine Br\u00e4nnvall (SE) : <\/b>Beep Insights \u2013\u00a0Calculating insulin resistance based on level of physical activity<\/span><\/p>\n <\/em><\/p>\n \u201cThe Beep app feature uses lactate measurement to estimate insulin resistance in relation to physical activity, CGM data, food\u00a0 intake and sleep. Beep has built the world\u2019s first in-app lactate step testing feature where both the test and the results are easily managed with a lactate testing device and analysed for you, without the need of any administration.\u201d<\/i><\/p>\n [\/et_pb_testimonial][et_pb_testimonial portrait_url=”https:\/\/www.dcberne.com\/wp-content\/uploads\/2024\/07\/Frederik-Plourde-credit-photo-Bruno-Petrozza-removebg-preview.jpg” quote_icon=”off” font_icon=”||divi||400″ portrait_width=”165px” portrait_height=”165px” _builder_version=”4.27.0″ _module_preset=”default” background_color=”RGBA(255,255,255,0)” width=”96.3%” custom_margin=”|151px||||” custom_padding=”|0px||||” global_colors_info=”{}”]<\/p>\n Fr\u00e9d\u00e9rik Plourde (CH) : <\/b>Neuria \u2013\u00a0Evidence-based Neurocognitive Digital Therapeutics to restore healthy consumption behaviors without awareness<\/span><\/p>\n <\/em><\/p>\n \u201cNeuria\u2019s gamified solution offers an evidence-based neurocognitive digital therapeutic that restores healthy consumption behaviors without awareness. Tested in 500+ individuals, it leverages brain plasticity and reduces cravings by 20%, consumption by 25%, and weight by 2-3% after a 15-hour intervention.\u201d<\/i><\/p>\n [\/et_pb_testimonial][et_pb_testimonial portrait_url=”https:\/\/www.dcberne.com\/wp-content\/uploads\/2024\/07\/Sufyan.jpg” quote_icon=”off” font_icon=”||divi||400″ portrait_width=”165px” portrait_height=”165px” _builder_version=”4.27.0″ _module_preset=”default” background_color=”RGBA(255,255,255,0)” width=”96.3%” custom_margin=”|151px||||” custom_padding=”|0px||||” global_colors_info=”{}”]<\/p>\n Sufyan Hussain (UK) : <\/b>Innodose \u2013 Device to reduce incidence of lipohypertrophy in long-term insulin users<\/span><\/p>\n <\/em><\/p>\n “INNODOSE gamifies the injection process to reduce the incidence of lipohypertrophy in insulin-treated diabetes \u2013 with a co-design informed innovation of a novel insulin pen and pen-adaptor, drawing on collaboration between academics, clinicians, practitioners, engineers and designers at King\u2019s College London, and with a focus on co-production with the end users.\u201d<\/i><\/p>\n [\/et_pb_testimonial][et_pb_testimonial portrait_url=”https:\/\/www.dcberne.com\/wp-content\/uploads\/2024\/07\/CGM.png” quote_icon=”off” font_icon=”||divi||400″ portrait_width=”165px” portrait_height=”165px” _builder_version=”4.27.0″ _module_preset=”default” background_color=”RGBA(255,255,255,0)” width=”96.3%” custom_margin=”|151px||||” custom_padding=”|0px||||” global_colors_info=”{}”]<\/p>\n Muhammad Mujeeb-U-Rahman (US): <\/b>CGM+ \u2013 Unleashing the Power of Next-Gen Monitoring for Diabetes<\/span><\/p>\n <\/i><\/p>\n \u201cIntegrated Medical Sensors (IMS) has developed the world\u2019s smallest, first fully-integrated (single chip) and first multi-sensor minimally invasive CGM, taking diabetes monitoring to the next level. It can monitor glucose using multiple independent sensors on the same device. In addition, it measures physiological parameters (e.g., tissue temperature) using the same device. Moreover, it can also measure multiple analytes (e.g., glucose and ketones) using a single device.\u201d<\/i><\/p>\n [\/et_pb_testimonial][et_pb_testimonial portrait_url=”https:\/\/www.dcberne.com\/wp-content\/uploads\/2024\/07\/Yuta-Matsuda.png” quote_icon=”off” font_icon=”||divi||400″ portrait_width=”165px” portrait_height=”165px” _builder_version=”4.27.0″ _module_preset=”default” background_color=”RGBA(255,255,255,0)” width=”96.3%” custom_margin=”|151px||||” custom_padding=”|0px||||” global_colors_info=”{}”]<\/p>\n Yuta Matsuda (US) : <\/b>Genomelink \u2013\u00a0Innovative DNA Testing: A New Horizon in Type 1 Diabetes Diagnosis<\/span><\/p>\n <\/em><\/p>\n \u201cMisdiagnosis between T1D and T2D is common due to a lack of accessible diagnostic methods. Our new DNA test offers a more accessible and accurate tool for diagnosis. Unlike the fluctuating antibody levels, genetic markers associated with T1D do not change over a person\u2019s lifespan, providing a stable diagnostic criterion.\u201d [\/et_pb_testimonial][et_pb_text ul_item_indent=”20px” ol_item_indent=”20px” module_id=”post-body” _builder_version=”4.22.1″ _module_preset=”default” text_font=”Calibri Regular||||||||” text_text_color=”#505358″ text_font_size=”18px” text_line_height=”24px” link_font=”||||on|||#89BBE5|” link_text_color=”#89BBE5″ custom_margin=”0px||80px||false|false” custom_margin_tablet=”0px||80px||false|false” custom_margin_phone=”||48px||false|false” custom_margin_last_edited=”on|phone” custom_padding=”0px||0px||false|false” global_colors_info=”{}”]<\/p>\n
<\/em><\/p>\n